Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Genetic Predisposition to Disease 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Mutation × Clear all
NCT05657210 2022-12-20

Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

Seoul National University Bundang Hospital

Completed
2,203 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03982446 2021-02-12

PaMPA

Hellenic Cooperative Oncology Group

Completed
549 enrolled
Gastrointestinal

Pancreatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡